Advicenne S.A. (3MM.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous Close | 1.5480 |
| Open | 1.5980 |
| Bid | 1.6460 x N/A |
| Ask | 1.6800 x N/A |
| Day's Range | 1.5900 - 1.6080 |
| 52 Week Range | 1.1200 - 4.0936 |
| Volume | |
| Avg. Volume | 30 |
| Market Cap | 20.021M |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7000 |
| Earnings Date | Mar 27, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.
PARIS, March 25, 2024--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, today announced that its proprietary drug ADV7103 has been granted Orphan Drug Designation (ODD) status for the treatment of cystinuria. This designation was issued by the US Food and Drug Administration (US FDA). ADV7103 is one of the few drugs t
- Business Wire
Advicenne Launches a Capital Increase With Preferential Subscription Rights ("PSR") to Accelerate Growth in Europe and Optimize Clinical Development of ADV7103
PARIS, September 11, 2023--Regulatory News: This press release must not be distributed directly or indirectly in the United States, Canada, Australia, or Japan.
© 2024 Yahoo. All rights reserved.